Drugs News and Research

RSS

New gene linked to schizophrenia and depression

A Scots-led medical research team has identified a new gene linked to major mental illness that links back to a previously discovered gene known to increase the risk of schizophrenia and depression.

20 Nov 2005

Genetically modified allow scientists to examine the potential usefulness of new therapies for Alzheimer's disease

Researchers with the University of Florida and the California Institute of Technology have developed a new strain of genetically modified mice that allow scientists to examine the potential usefulness of new therapies for Alzheimer's disease.

20 Nov 2005

Cholesterol lowering drugs, including statins, may slow the progression of Alzheimer's disease

Cholesterol lowering drugs, including statins, may slow the progression of Alzheimer's disease, concludes a study in the Journal of Neurology Neurosurgery and Psychiatry.

20 Nov 2005

The Medicare Drug Benefit: A Prescription for Confusion

If many seniors are scratching their heads about the new Medicare prescription drug plan, so are the experts.

20 Nov 2005

Aspirin advice ignored by those who need it

A daily dose of aspirin is an inexpensive, proven strategy for reducing the likelihood of heart disease among those most at risk for such disorders, yet a new study from the Stanford University School of Medicine shows that aspirin therapy is being used by fewer than one-third of the U.S. outpatients who would benefit from it.

20 Nov 2005

Double the weight-loss when counseling is combined with diet drugs

According to a new study, obese patients who took the diet drug Meridia and received intensive weight-loss counseling, lost twice as much weight as patients who only took the drug.

20 Nov 2005

UN says AIDS in India far worse than figures show

According to a UN Aids expert, the number of new HIV cases in India is far more than official data shows and epidemics in some pockets are alarming.

20 Nov 2005

Scientists discover gene which controls fear

Scientists have discovered the existence of a gene that appears to control whether fear reactions to impending danger are appropriate or not.

20 Nov 2005

Bird flu spreads in China while Bush's $ 7.1 billion pandemic fund stalls

As World health experts predicted there will be more human bird flu infections in China, the U.S. Congress has stalled the funding of President George W. Bush's plan to cope with a pandemic.

20 Nov 2005

Six gene variants predict heart muscle damage after cardiac surgery

Duke University Medical Center researchers have found that patients with six specific variants of genes involved in the body's immune response are significantly more likely to suffer damage of heart tissue after cardiac surgery.

16 Nov 2005

Haphazard activation of secondary signaling pathways may fuel cancer's genesis

When found at abnormally high concentrations, two proteins implicated in many human cancers have the potential to spur indiscriminate biochemical signaling inside cells, chemists at Harvard University have found.

16 Nov 2005

Carvedilol may improve heart failure and help prevent sudden death

Research shows that Carvedilol, a cardiovascular drug, could be useful in reducing cardiac death in high risk patients with prior myocardial infarction and/or heart failure and also in reducing the incidence and/or preventing the occurrence of atrial fibrillation in a number of clinical situations.

16 Nov 2005

Tamoxifen reduces long-term risk of cancer

According to a new study released this week, women at high risk for breast cancer who take the well-known drug Tamoxifen, can reduce their long-term risk of developing the disease.

16 Nov 2005

Cannabis-based medicine given go-ahead to treat MS patients

Sufferers in the UK from multiple sclerosis and possibly rheumatoid arthritis, will welcome the news that they will soon be able to obtain an unlicensed, cannabis-based medicine on prescription to treat their illness.

16 Nov 2005

Row over Plan B unearths suspicion of political manipulation

Congressional investigators are saying there is a suspicion that senior U.S. Food and Drug Administration (FDA) officials may have decided to reject a politically sensitive request for over-the-counter sales of a "morning-after" contraceptive months before agency scientists finished reviewing the scientific data.

16 Nov 2005